Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-24 @ 10:02 PM
NCT ID:
NCT00043732
Eligibility Criteria:
Inclusion Criteria:
* Patients who have active rheumatoid arthritis and are receiving methotrexate
* meet the revised 1987 American Rheumatism Association (ARA) criteria for rheumatoid arthritis
* has active RA as demonstrated by 9 tender and 6 swollen joints and one of the following: C-reactive protein 1.0 mg/dL, Erythrocyte sedimentation rate (ESR) 28 mm/hour, or Morning stiffness = 45 minutes. .
Exclusion Criteria:
* Patient used etanercept, infliximab, anakinra, or an experimental biologic agent within past 3 months
* Had elevation of liver enzymes within past 6 months
* Has a history of Tuberculosis
* Vertigo, inner ear, or vestibular abnormalities
* Cancer
* HIV-positive
* Abnormal electrocardiogram
* patient has chronic or acute infection
* Multiple sclerosis, neuropathy or encephalopathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00043732
Study Brief:
Protocol Section:
NCT00043732